- Research
- Open access
- Published:
Feasibility test of WORK-ON: a vocational rehabilitation intervention for people with chronic inflammatory arthritis
BMC Musculoskeletal Disorders volume 25, Article number: 755 (2024)
Abstract
Background
People with chronic inflammatory arthritis (IA) often have a reduced work ability. Consequently, they are at high risk of losing their jobs and being permanently excluded from the labor market. Therefore, we developed a new context-specific vocational rehabilitation intervention for people with IA based on the Medical Research Council’s framework for complex interventions. This intervention is called “WORK-ON” and consists of: (1) Initial assessment and goal setting by an occupational therapist experienced in rheumatology rehabilitation; (2) coordinated support from the same occupational therapist, including assistance in navigating the primary and secondary healthcare and social care systems; (3) group sessions for peer support; and (4) individually tailored consultations with physiotherapists, nurses, and/or social workers. This study investigates the feasibility of WORK-ON.
Methods
A 6-month single-arm feasibility study with a pre-test post-test design was conducted to evaluate recruitment, intervention fidelity and delivery, data collection, and possible outcome measures. Work ability was the primary outcome, and sick leave, quality of life, fatigue, pain, physical activity, sleep, and well-being were the secondary outcomes evaluated.
Results
In total, 19 participants (17 women and 2 men) with a median age of 55 years (range, 34–64) participated and completed WORK-ON. Of these, 17 participants completed patient-reported outcomes at baseline and follow-up, and the results indicated a tendency to improvement in work ability, quality of life, level of physical activity, decrease in pain, and increase in days of sick leave during the 6-month intervention period. The rehabilitation clinicians spent an average of 15.3 h per participant, and the participants spent an average of 13.5 h in the intervention.
Conclusions
WORK-ON is considered feasible and has the potential to increase work ability among people with IA who are concerned about their future ability to keep working. Though, an adjustment of the intervention is needed before testing in a randomized controlled trial.
Background
Impaired work ability is common among people with chronic inflammatory arthritis (IA), which includes rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), and psoriatic arthritis (PsA). Approximately 30–40% of people with IA do not tolerate or derive sufficient benefits from pharmacological treatment [1,2,3]. People with IA often experience functional impairments, anxiety, depression, and disturbed sleep, and more than 50% of patients experience substantial fatigue and pain [1, 4,5,6]. Consequently, they have a high risk of losing their jobs and being permanently excluded from the labor market [7,8,9,10]. Up to 40% of those with IA lose their jobs within the first few years of being diagnosed, and they find it difficult to return to work [7, 8, 11,12,13,14,15]. Therefore, early support is crucial to enable people with IA to continue in paid employment. Challenging aspects of work, such as physically demanding tasks, stationary work, or varied working hours, can lead to increased sick leave among people with IA, compared with the general population [16, 17]. The direct and indirect costs of IA—primarily, the expensive treatments required and patients’ reduced capacities for work—are substantial, affecting both individuals and societies [11, 18].
Participation in paid work is important for an individual’s sense of identity and belonging; their self-esteem, everyday routine, and social relationships; and their ability to fulfil societal expectations [19,20,21,22,23,24]. Vocational rehabilitation (VR) is often complex and involves various professionals and interventions [18]. Few studies have described the effects of VR on people with IA, but our previous systematic review showed VR can affect work ability, sick leave, and job loss among people with IA [18]. Using the Medical Research Council’s (MRC) framework for developing and testing complex interventions [25], we developed a VR intervention called “WORK-ON” [26]. The aim of WORK-ON is to increase work ability and decrease sick leave and job loss in the longer term. WORK-ON is based on evidence from our previous systematic review [18], interviews with people with IA who consider themselves at risk of losing their job [16], and input from rehabilitation clinicians (RCs) and employers [26, 27]. We included in the intervention occupational balance [28], self-management [29], shared decision-making (SDM) [30], and Focused Acceptance and Commitment Therapy (FACT) [31] as key theories and approaches. Further, a logic model was developed to highlight the relationships between activities and expected outcomes, and outcome measures were chosen based on this information [26].
The MRC framework recommends using a feasibility test to evaluate eligibility criteria, recruitment, outcomes, fidelity, and delivery of interventions prior to conducting a randomized controlled trial (RCT) [25]. Therefore, this study sought to evaluate the feasibility of WORK-ON, focusing on the recruitment procedure, intervention fidelity and delivery, data collection, possible outcome measures, and the optimal primary outcome measure for a subsequent RCT.
Methods
Design and setting
We performed a single-arm 6-month feasibility study at the Danish Hospital for Rheumatic Diseases (DHRD; Soenderborg, Denmark). Participants were recruited from the outpatient department at the DHRD. The Regional Committees on Health Ethics for Southern Denmark stated no formal ethical approval was necessary for this study (journal number, 20192000-105). Findings were reported in accordance with the Consolidated Standards of Reporting Trials (CONSORT) statement for pilot and feasibility studies [32].
Intervention content
WORK-ON was implemented over a period of 6 months and was planned to include 6 to 18 consultations (approximately 14–21 h), including group sessions, depending on participant needs. WORK-ON included the following four elements:
-
1.
Initial assessment by an occupational therapist (OT) experienced in rheumatology rehabilitation using the Work Experience Survey for Patients with Rheumatic Conditions (WES-RC) [33], followed by setting goals and planning actions based on SDM [30].
-
2.
Coordination and support of individual self-management by the same OT throughout the VR to achieve occupational balance in everyday life [28, 29]. This included support in navigating the primary and secondary healthcare and social care systems, as well as access to the municipal job center. The coordinating OT could schedule a minimum of three consultations with each participant.
-
3.
Three group sessions for education and peer support: one session with a social worker focusing on legislation, one with a nurse focusing on acceptance of the disease in relation to work, and one with an OT focusing on coping strategies. The group sessions were followed by a consultation with the coordinating OT to determine whether the participant needed individual consultations with other RCs at the DHRD.
-
4.
Optional individually tailored VR consultations: a maximum of two consultations per RC, depending on the participants’ needs and goals. These included consultations with physiotherapists to recommend individually tailored physical activities and exercise; with nurses to better understand the disease and how to manage fatigue and pain; with social workers to understand legislation; and with OTs to recommend hand exercises, small aids, and supervision in ergonomic positions (Fig. 1).
Other details of the development, content, and timeline of the intervention are provided elsewhere [26].
Eligibility criteria
The inclusion criteria were:
-
1.
age ≥ 18 years.
-
2.
diagnosed with RA, axSpA, or PsA.
-
3.
in paid work (full-time or part-time, self-employed) or full-time education
-
4.
if on sick leave, had to have been for less than four weeks.
-
5.
able to read and understand Danish.
-
6.
willing to participate in group sessions.
-
7.
answered “unlikely” or “not certain” to question 6 from the Work Ability Index (WAI) questionnaire: “Do you believe, according to your present state of health, that you will be able to do your current job two years from now?” [34].
The exclusion criteria were:
-
1.
not able to attend WORK-ON because of cognitive issues.
-
2.
having / will be having changes in the pharmacological treatment expected to affect work ability.
-
3.
major surgery within the past six months or planned surgery.
-
4.
under investigation for other severe comorbidities.
-
5.
problems retaining work due to comorbidities other than IA, such as psychiatric illness, heart disease, cancer, or chronic obstructive pulmonary disease.
-
6.
undergoing / due to undergo other rehabilitation in the hospital or municipality.
Recruitment procedure
All outpatients with IA completed questionnaires for the national quality database DANBIO using a touchscreen or computer before each outpatient consultation at the DHRD [35]. For patients with RA, axSpA, or PsA aged ≥ 18 years, the regular questionnaires were followed by an extra question asking whether they were currently in paid employment. If they were, then question #6 from the WAI questionnaire was asked: “Do you believe, according to your present state of health, that you will be able to do your current job two years from now?” [34]. Patients who answered “unlikely” or “not certain” were encouraged to insert their phone number if they were interested in hearing about a new offer of support for maintaining employment: WORK-ON.
The first author (CTM) contacted the interested patients by phone and screened them using the eligibility criteria. Eligible patients were offered further information about the study and written participant and consent information was sent to them by e-mail. If a patient agreed to participate, their written consent was collected before the first WORK-ON consultation. A baseline questionnaire was sent to each participant’s e-mail address using Research Electronic Data Capture (REDCap). REDCap is a secure web application for building and managing online surveys. Sociodemographic and disease-related information was collected in addition to the completed questionnaires.
Intervention delivery
The RCs who delivered WORK-ON received 8 h of training prior to commencing the feasibility study. This included information on the background, content, development, and design of WORK-ON, as well as on procedures for the group sessions, individual consultations, booking, and attendance registration. Furthermore, the RCs, which practice a person-centered approach at the DHRD, also received training in FACT [31] during four 2-hour modules at the start of the feasibility study. A person-centered approach and FACT are important elements of WORK-ON. The training was delivered by members of the research team (CTM and JP) and a psychologist. In addition, the coordinating OTs received 3 h of training in using the WES-RC [33].
Intervention fidelity
To study fidelity, journal entries were read to assess whether the intervention was delivered as described in the manual. Furthermore, for each participant, the RCs completed a logbook with the following information: date, type of consultation, time required during and after the consultation, materials offered to the participant (e.g., pamphlets), referrals to other RCs, and professional skills used, as well as ideas to improve the manual and any successes or challenges experienced in each consultation. There were learning meetings throughout the intervention period with the RCs and CTM. To conduct a process evaluation, two focus group interviews with the RCs, along with semi-structured interviews with the participants completing WORK-ON, were planned. The results from the process evaluation will be reported elsewhere.
Outcome measures
Demographic information (e.g., age, sex, diagnosis, year of diagnosis, and marital status) was collected at baseline. Patient-reported outcome measures were recorded at baseline and at the end of the intervention (6 months later).
Two possible primary outcome measures (the WAI single item and the Work Productivity and Activity Impairment Questionnaire: General Health [WPAI: GH]) were tested in the feasibility study to determine which to use as the primary outcome in a subsequent RCT (Table 1). Following the MRC framework, outcome measures were selected using the available evidence, the underlying intervention theories, and the logic model [25]. Information on employment status (e.g., in full-time work, part-time work, self-employed, flexi-job, or in full-time education) was collected at baseline and at the end of the 6-month intervention.
Cognitive interviewing was used to test the readability, explanatory text, and response options of the outcome measures prior to the feasibility test [44]. Three patients who fulfilled the study inclusion criteria were asked to complete the questionnaires with the first author present. While completing the questionnaires, the patients were encouraged to comment if something was unclear or imprecise and on whether the number of questions was acceptable [44]. These interviews did not lead to any changes in the choice of patient-reported outcome measures.
Data analysis
Data from the 17 participants who completed baseline and 6-month follow-up assessments were included in the analysis, as recommended by CONSORT [32]. The patient-reported outcome measures were scored in accordance with the developers’ recommendations. Descriptive statistics were used to describe participants’ characteristics. Medians and interquartile ranges were used for continuous data because of the small sample size. Frequencies and percentages were used for categorical data. The mean was used to report sick leave so these data could be compared with data from Statistics Denmark. The questions about pain and sleep were from a Danish National Health Profile and had no scoring instructions [41]. For the questions about pain, two categories were merged (“none” and “slight”) and for questions about sleep, two categories were merged (“less than once a week” and “1–2 times a week”) because of the low number of participants. Statistical analyses were performed using Stata software (ver. 17; StataCorp, College Station, TX, USA).
Results
Recruitment and inclusion
Between May and October 2022, 119 potentially eligible patients answered “unlikely” or “not certain” to question 6 from the WAI questionnaire [34]. Of those, 55 (46%) did not want information about WORK-ON and 64 (54%) indicated an initial interest in hearing more about the intervention. These 64 patients were contacted to assess whether they met the inclusion criteria, and those who did received more information about WORK-ON. In total, 18 of the 64 patients (28%) failed to meet the inclusion criteria and 27 patients (42%) declined to participate for various reasons (Fig. 2). Thus, 19 patients (30%) were included in the WORK-ON feasibility study.
All 19 participants completed the 6-month WORK-ON intervention. In total, 17 participants (89%) completed both the baseline and the 6-month follow-up questionnaires (Fig. 2).
Participants
The participants were 17 women and two men aged from 34 to 64 years (Table 2). In total, 15 of the participants were diagnosed with RA, two with axSpA, and two with PsA. The median disease duration was 9 years (range, 1–18 years). Additional sociodemographic information about the participants is listed in Table 2.
Intervention delivery
Attendance and time spent in the VR are illustrated in Table 3. Time spent with the patient, documenting, and collaborating with other professionals was included in the calculations. Because of sick leave, 5 of the 19 participants were not able to attend all three group sessions and were offered individual consultations as compensation—these consultations are included in the number of individual consultations. The participants were encouraged by the coordinating OT to involve their employer. Twelve participants wanted to speak to their employers directly, without involving the coordinating OT. In these cases, the coordinating OT followed up on this part through the VR. One participant wanted to involve their employer in the VR, but the employer did not want to participate. Six of the participants involved the municipal job center, but only one participant included the coordinating OT in the contact. The participants spent an average of 13.5 h (range, 8.5–18.5) on the intervention during the 6-month study period.
Intervention fidelity
Intervention fidelity was assessed based on journal and logbook entries. Four learning meetings with the RCs (1 h each) were held during the intervention period. These meeting times are not included in the calculations in Table 3.
Based on an initial assessment using a Danish translation of the WES-RC [33], participants identified and prioritized their occupational problems and set goals via SDM together with the coordinating OT [30]. Goals encompassed aspects such as clarification on whether the participant had the right job or wanted to become better at saying no in pressured work situations. After the initial assessments and goal setting, the participants attended group sessions. Participants were organized into one of three groups: one group had seven participants and the other two had six participants each. The RCs used the WORK-ON manual to plan and conduct the group sessions. The coordinating OT assessed the need for individual consultations over the 6-month intervention period in collaboration with each participant in accordance with the person-centered approach described in the manual.
Outcome measures
Primary outcomes
For the WAI, nine participants reported an improvement in their work ability. Only 13 of the participants completed the WPAI: GH, why these results are difficult to interpret (Table 4).
Because the sample size was small, the study was not powered to show significant changes in the outcome measures.
Sick leave
The 19 participants reported an average of 2.8 days (range, 0–112 days; median, 10 days) of sick leave measured by text messages per month. In addition, several participants revealed in their text messages that they felt they should have taken days of from work because of the impact of their IA but did not.
One participant went on full-time sick leave immediately after inclusion in WORK-ON and accumulated 112 days of sick leave during the intervention period. Another participant went on full-time sick leave in the final 3 months of the intervention, leading to an increase in the total number of days of sick leave during months 4–6, as shown in Fig. 3. Further, employees in part-time work had more days of sick leave than those in full-time work. Participants working full-time had an average 1 day of sick leave (median, 4 days) per month and those working part-time had an average 5.8 days of sick leave (median, 23 days) per month. Both the participants who went on full-time sick leave worked part-time.
Discussion
The study reported here evaluated the feasibility of WORK-ON, with a focus on recruitment procedure, intervention fidelity and delivery, feasibility of outcome measures, and evaluation of which outcome measure to use as the primary outcome measure in a subsequent RCT. The findings from this study are from a Danish context, but can be used in VR in other countries. Overall, the study demonstrated WORK-ON is feasible and suitable for people with IA. However, in the recruitment process, a majority (69%) of the patients who had indicated they wanted to hear more about the study following the initial screening either did not want information about WORK-ON (n = 55) or declined to participate in the intervention for various reasons (n = 27). WORK-ON is a complex intervention addressing several issues, and involvement requires active engagement from the participant. Some of the patients who declined participation may have perceived the intervention as too comprehensive and interfering too much with their work and daily life. Another possible challenge patients may have perceived is the need to balance work with other occupations in everyday life, potentially resulting in a lack of energy to participate in WORK-ON.
Further, 13 of the 19 participants had a higher level of education and only two were men. This raises the question of whether the intervention primarily targets women with a higher social status and, consequently, leads to the exclusion of eligible patients with a high need for VR. Therefore, we must consider whether the current version of WORK-ON contributes to social inequality and, if so, how to avoid this. Research indicates social factors such as low education, low income, and unemployment are closely linked to health [45]. Moreover, higher wages and educational levels are associated with a reduced risk of long-term sick leave and early retirement [46]. In the recruitment process, possible participants were shown a pop-up text with a short text about the study after completion of a battery of questions in DANBIO. If some patients found reading and understanding this text difficult because of low health literacy [47], this could be a potential barrier to participation. Further, the text contained information about how many hours and consultations participants might spend in the intervention, which may have discouraged some from hearing more about the study and participating. Thus, adjustment of the pop-up text may be necessary. In a future RCT, recruitment can also involve the clinical staff of rheumatologists and nurses in the outpatient clinic, as they can introduce WORK-ON during consultations with eligible patients. This approach may enable inclusion of eligible patients.
In the individual consultations, participants consulted the social worker more than the other RCs. Journal entries revealed participants needed to discuss their options for economic support and compensatory schemes because of their employment situations. The physiotherapist and the nurse were consulted less frequently than expected. In the feasibility study, the physiotherapist was not present in the group sessions; therefore, participants may have been less likely to ask for a physiotherapy consultation if they did not have a clear understanding of what the physiotherapist could offer. There might not have been enough focus on how a physiotherapist could support participants in physical activity or the importance of physical activity, which should be in focus in a future study. However, the nurse was present in the group sessions but only three participants asked for a nursing consultation. As part of their standard care in the outpatient department, the participants already had regular appointments with a rheumatology nurse. They may not have understood that, in WORK-ON, the nurses did not have to spend time assessing blood tests and responses to questionnaires or performing joint assessments as in their usual nursing consultations, and thus there were greater opportunities for support to understand and manage (i.e., the pain and fatigue) their disease. There is a need for more focus on fatigue in a subsequent RCT, as fatigue is one of the main challenges for people with IA in work [16].
Both the WAI single item and WPAI: GH have been recommended for measuring at-work productivity loss (presenteeism), which is a major problem in people with IA [7, 11, 48]. The WAI single item has been shown to be a reliable short substitute for the more extensive WAI and to have acceptable convergent validity [49]. Still, the WAI single item only refers to the participants’ current work ability on a scale from 0 to 10 [49]. The WAI single item has been criticized for not being able to identify the risk of disability pension or long-term sick leave, and being too simple for not allowing specific determinants of work ability to be identified, although the short form of the WAI single item is simple to interpret and may increase completion rates [50].
The WPAI: GH evaluates four outcomes: absenteeism, presenteeism, overall work impairment, and activity impairment [37]. In the feasibility test, we obtained slightly different results from the WPAI: GH in relation to work productivity and overall work impairment than other studies with similar target groups [51,52,53]. This may be because the few participants in the feasibility test had lower levels of work productivity and higher degrees of overall work impairment than the participants in the other studies [51,52,53]. This could be due to the recruitment process or the small sample size in present study. Notably, only 13 out of 19 participants completed the WPAI: GH. The cognitive interviews we undertook with three patients prior to the feasibility test indicated no problems in understanding or completing the WAI single item or the WPAI: GH, but the three patients may not be representative of the study population. Another study found the formulation of the questions in WPAI: GH and the word “productivity” may be difficult to understand if participants’ work does not involve “production of products” [48]. To ensure a higher response rate from the WPAI: GH, when developing the REDCap questionnaire, a future RCT should ensure all questions are marked as “required” so that participants cannot proceed with the questionnaire until the question is answered. Therefore, the WPAI: GH may not considered suitable as a primary outcome measure for a subsequent RCT. Work ability is important, as it may serve as an indicator for future long-term sick leave, early retirement, and job loss [46]. While job loss could be considered a potential primary outcome, a power calculation suggests recruiting sufficient participants within a reasonable timeframe and a long follow-up may be challenging, as reduction of job loss will probably be a long-term outcome in accordance with our logic model for the association between job loss and work ability [26]. The WAI single item can be considered a proxy for subsequent job loss, and it is a simple question to answer [34]. As there is no validated Danish version of the full WAI questionnaire, we may choose the WAI single item as the primary outcome measure in a subsequent RCT.
An unintended consequence we identified through the feasibility study was an increase in sick leave, and one of the aims of WORK-ON was to decrease sick leave. When assessing intervention fidelity, we found the coordinating OTs encouraged the participants to take more sick leave to increase their ability to self-manage their lives, improve their occupational balance, and enhance their capacity to continue paid work. This may lead to decreased presenteeism at work, but it was a key uncertainty we did not anticipate from the beginning. Some participants had a compensatory scheme (a legal agreement) with the municipality (called a “§ 56” in Denmark) where they can take a minimum of 10 days of sick leave because of their IA, and the employer receives economic compensation from the municipality. Often, patients do not use this agreement in consideration of their colleagues and employer, but they will lose the § 56 if they do not use it at least 10 days per year. Therefore, participants may have been encouraged to increase their sick leave days after starting the intervention. Overall, increased sick leave is unacceptable from a socio-economic perspective. This calls for a discussion of the need for additional adjustments and support as part of WORK-ON to enable participants to manage their work. Further, given the feasibility study was not a randomized design, we lack the ability to discern whether sick leave differed from a control group. According to Statistics Denmark, in 2021, men had 6.9 days of sickness absenteeism per year and women 11.8 days on average [54]. A Danish report from 2017 mentions that people with RA had 5.6 more days away from work because of illness than the general population in Denmark, which aligns with our findings [55]. People with IA experience a mean productivity loss of 23.5% each week in 2020 according to a small Danish study [53]. Likewise, a report from the University of Southern Denmark in 2022 showed sick leave was more frequent among people with musculoskeletal disorders (23.4%) than among people without them (16.5%) [56]. Further, in present study there seemed a tendency to more sick leave among participants in part-time work compared with participants in full-time work. Those in part-time work may already have been through a process of accepting their disease and managed their condition by working fewer hours.
None of the participants wanted to involve the coordinating OT in contact with their employer. This is in line with another feasibility study testing job retention for people with IA in the United Kingdom, which found few participants wanted to involve their employer [57].
Finally, we developed a logic model for WORK-ON [26] and found several of our assumptions were confirmed. For example, the results indicated improvements in quality of life, physical activity, and pain reduction. These improvements could be due to increased focus on energy management and coping strategies, decreasing the impact of IA. However, the logic model did not show improvements in outcome measures for occupational balance and mental well-being as we anticipated [26].
Strengths and limitations
A major strength of our WORK-ON study was that it was carried out at the DHRD, which has specialized resources for rehabilitating people with rheumatic diseases and access to RCs who practice a person-centered approach, are skilled in FACT and goal setting, which are key elements of WORK-ON. Therefore, the RCs have expertise in the biopsychosocial rehabilitation of people with IA. Importantly, this feasibility study was not intended or powered to find statistically significant differences in the two primary outcomes tested. A limitation was the missing information for two of the participants in the outcomes measures, and six of the participants did not complete the WPAI: GH. Another limitation was no employers were involved directly. Employers are important stakeholders in VR, and evidence shows employers want involvement in VR and are prepared to adjust work activities and arrange flexible working hours for employees [27]. A subsequent RCT should place more emphasis on involving employers to ensure VR is successful. However, respecting a participant’s decision not to involve their employer is also important. A third limitation is that we did not include observations as part of the assessment of intervention fidelity but only journal and logbook entries. Notably, some participants reported comorbidities not identified during eligibility screening (e.g., stroke, cancer, and depression). Because these data were self-reported, whether these comorbidities had an impact on the participants’ work ability is uncertain. In addition, one eligible patient planned to retire within six months. Our eligibility criteria and recruitment should be refined to take these issues into account for a subsequent RCT.
Conclusion
The WORK-ON intervention is considered feasible, although some adjustments are needed before testing in a subsequent RCT. Recruitment should be adjusted to include rheumatologists and nurses in the outpatient clinic. In general, there is a need to focus more on the use of FACT and fatigue management. Further, a focus on how to prevent sick leave by adjusting participants’ work environment and employer involvement is necessary. Finally, the logic model needs to be modified to describe what happens and what works for whom, and further training of the RCs in fatigue needs to be planned and delivered.
We believe an adjusted version of WORK-ON has the potential to support patients with IA to increase their work ability, resulting in a reduction in job loss. The WAI single item may be used as the primary outcome and job loss as a secondary outcome in a subsequent RCT. A full evaluation of costs in relation to outcomes is planned as part of a subsequent RCT.
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- AxSpA:
-
Axial spondyloarthritis
- BRAF-NRSv2:
-
Bristol Rheumatoid Arthritis Fatigue Numeric Rating Scales version 2
- CONSORT:
-
Consolidated Standards of Reporting Trials
- DHRD:
-
Danish Hospital for Rheumatic Diseases
- EQ-5D-5L:
-
European Quality of Life—5 Levels
- EQ-VAS:
-
EuroQol Visual Analogue Scale
- FACT:
-
Focused acceptance and commitment therapy
- IA:
-
Inflammatory arthritis
- IQR:
-
Interquartile range
- MRC:
-
Medical Research Council
- OBQ-11:
-
Occupational Balance Questionnaire
- OT:
-
Occupational therapist
- PsA:
-
Psoriatic arthritis
- RA:
-
Rheumatoid arthritis
- RCT:
-
Randomized controlled trial
- REDCap:
-
Research Electronic Data Capture
- VR:
-
Vocational rehabilitation
- WAI:
-
Work Ability Index
- WES-RC:
-
Work Experience Survey—Rheumatic Conditions
- WHO:
-
World Health Organization
- WPAI:
-
Work Productivity and Activity Impairment Questionnaire: General Health
References
Cook MJ, Diffin J, Scire CA, Lunt M, MacGregor AJ, Symmons DP, et al. Predictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register. Rheumatology (Oxford). 2016;55(9):1601–9.
van Mens LJJ, van de Sande MGH, Fluri IA, Atiqi S, van Kuijk AWR, Baeten DLP. Residual disease activity and treatment adjustments in psoriatic arthritis in current clinical practice. Arthritis Res Ther. 2017;19(1):226.
Liu V, Fong W, Kwan YH, Leung YY. Residual Disease Burden in patients with Axial Spondyloarthritis and Psoriatic Arthritis despite Low Disease Activity States in a multiethnic Asian Population. J Rheumatol. 2021;48(5):677–84.
Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Ellingsen T, Andersen LS, et al. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthrit Rheum. 2006;54(5):1401–9.
Horslev-Petersen K, Hetland ML, Ornbjerg LM, Junker P, Podenphant J, Ellingsen T, et al. Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA). Annal Rheum Dis. 2016;75(9):1645–53.
Pilgaard T, Hagelund L, Stallknecht SE, Jensen HH, Esbensen BA. Severity of fatigue in people with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis – results of a cross-sectional study. PLoS ONE. 2019;14(6):e0218831–e.
Sokka T, Kautiainen H, Pincus T, Verstappen SMM, Aggarwal A, Alten R, et al. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthrit ResTher. 2010;12(2):R42–R.
Hansen SM, Hetland ML, Pedersen J, Ostergaard M, Rubak TS, Bjorner JB. Effect of rheumatoid arthritis on longterm sickness absence in 1994–2011: a Danish cohort study. J Rheumatol. 2016;43(4):707–15.
Boonen A, Vet Hd H, Dvd, Linden Svd. Work status and its determinants among patients with ankylosing spondylitis. A systematic literature review. J Rheumatol. 2001;28(5):1056–62.
Cooper NJ. Economic burden of rheumatoid arthritis: a systematic review. Rheumatology. 2000;39(1):28–33.
Uhlig T, Moe RH, Kvien TK. The burden of disease in rheumatoid arthritis. PharmacoEconomics. 2014;32(9):841–51.
Verstappen SMM, Bijlsma JWJ, Verkleij H, Buskens E, Blaauw AAM, ter Borg EJ, et al. Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Rheum. 2004;51(3):488–97.
Verstappen SMM, Watson KD, Lunt M, McGrother K, Symmons DPM, Hyrich KL, et al. Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology. 2010;49(8):1570–7.
Verstappen SMM, Boonen A, Bijlsma JWJ, Buskens E, Verkleij H, Schenk Y, et al. Working status among Dutch patients with rheumatoid arthritis: work disability and working conditions. Rheumatology (Oxford). 2005;44(2):202–6.
Hansen SM, Hetland ML, Pedersen J, Østergaard M, Rubak TS, Bjorner JB. Work ability in rheumatoid arthritis patients: a register study on the prospective risk of exclusion and probability of returning to work. Rheumatology (Oxford). 2017;56(7):1135–43.
Madsen CMT, Christensen JR, Bremander A, Primdahl J. Perceived challenges at work and need for professional support among people with inflammatory arthritis - a qualitative interview study. Scand J Occup Ther. 2021;(30):1–10.
Beaton D, Bombardier C, Escorpizo R, Zhang WEI, Lacaille D, Boonen A, et al. Measuring Worker Productivity: Frameworks and measures. J Rheumatol. 2009;36(9):2100–9.
Madsen CMT, Bisgaard SK, Primdahl J, Christensen JR. Von Bülow C. A systematic review of job loss Prevention interventions for persons with inflammatory arthritis. J Occup Rehabil. 2021;31(4):866–85.
Kristiansen TM, Primdahl J, Antoft R, Hørslev-Petersen K. Everyday life with rheumatoid arthritis and implications for Patient Education and clinical practice: a Focus Group Study. Musculoskelet Care. 2012;10(1):29–38.
Wilkie R, Bjork M, Costa-Black KM, Parker M, Pransky G. Managing work participation for people with rheumatic and musculoskeletal diseases. Best Pract Res Clin Rheumatol. 2020;34(2):101517.
Madsen M, Jensen KV, Esbensen BA. Men’s experiences of living with Ankylosing spondylitis: a qualitative study. Musculoskelet Care. 2015;13(1):31–41.
Primholdt N, Primdahl J, Hendricks OA, Difficult Diagnosis. A qualitative study of the Daily Lives of Young Men Diagnosed with Ankylosing spondylitis: Young men with Ankylosing Spondylitis. Musculoskelet Care. 2017;15(2):140–9.
Feddersen H, Kristiansen TM, Andersen PT, Hørslev-Petersen K, Primdahl J. Construction of meaningful identities in the context of rheumatoid arthritis, motherhood and paid work: a meta‐ethnography. J Clin Nurs. 2017;26(23–24):4117–28.
Feddersen H, Mechlenborg Kristiansen T, Tanggaard Andersen P, Hørslev-Petersen K, Primdahl J. Juggling identities of rheumatoid arthritis, motherhood and paid work - a grounded theory study. Disabil Rehabil. 2019;41(13):1536–44.
Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ (Online). 2021;374:n2061.
Madsen CMT, Primdahl J, Bremander A, Eggen L, Christensen JR. Developing a complex vocational rehabilitation intervention for patients with inflammatory arthritis: the WORK-ON study. BMC Health Serv Res. 2023;23(1):739.
Madsen CMT, Frølund J, Leach WJ, Primdahl J, Bremander A, Christensen JR. POS0212-HPR vocational rehabilitation for people with inflammatory arthritis – an employer perspective. Ann Rheum Dis. 2023;82(Suppl 1):332–3.
Wagman P, Håkansson C, Björklund A et al. Hhj Afr, välfärd HHJKoliho, Högskolan i J,. Occupational balance as used in occupational therapy: A concept analysis. Scand J Occup Ther. 2012;19(4):322-7.
Grady PA, Gough LL. Self-management: a comprehensive approach to management of chronic conditions. Am J Public Health (1971). 2014;104(8):e25–31.
Elwyn G, Durand MA, Song J, Aarts J, Barr PJ, Berger Z, et al. A three-talk model for shared decision making: multistage consultation process. BMJ. 2017;359:j4891–j.
Strohsal KD, Robinson PJ, Gustavsson T. Brief interventions for radical behavior change: principles and practice of focused acceptance and commitment therapy. Oakland, CA: New Harbinger; 2021.
Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ (Online). 2016;355:i5239–i.
Allaire S, Keysor JJ. Development of a structured interview tool to help patients identify and solve rheumatic condition-related work barriers. Arthrit Rheum. 2009;61(7):988–95.
Tuomi KIJ, Jahkola A, Katajarinne L, Tilkki A. Work Ability Index, 2nd Edition: Finish Institute of Occupational Health, Helsinki; 1998.
Hetland ML. DANBIO—powerful research database and electronic patient record. Rheumatology. 2011;50(1):69–77.
Gupta N, Jensen BS, Søgaard K, Carneiro IG, Christiansen CS, Hanisch C, et al. Face validity of the single work ability item: comparison with objectively measured heart rate reserve over several days. Int J Environ Res Public Health. 2014;11(5):5333–48.
Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics. 1993;4(5):353–65.
Morville A-L, Håkansson C, Wagman P, Hansen T, editors. Validity of the Danish version of Occupational Balance Questionnaire (OBQ-DK)2016.
Håkansson C, Wagman P, Hagell P. Construct validity of a revised version of the Occupational Balance Questionnaire. Scand J Occup Ther. 2020;27(6):441–9.
Jensen MB, Jensen CE, Gudex C, Pedersen KM, Sørensen SS, Ehlers LH. Danish population health measured by the EQ-5D-5L. Scand J Pub Health. 2021:14034948211058060-.
The National Healthprofile (How are you?). 2021 [ https://www.sdu.dk/da/sif/forskning/projekter/den_nationale_sundhedsprofil
Primdahl J, Esbensen BA, Pedersen AK, Bech B, de Thurah A. Validation of the Danish versions of the Bristol rheumatoid arthritis fatigue multi-dimensional questionnaires (BRAFs). Scand J Rheumatol. 2021;50(5):351–9.
Topp CW, Østergaard SD, Søndergaard S, Bech P. The WHO-5 well-being index: a systematic review of the literature. Psychother Psychosom. 2015;84(3):167–76.
Beatty PC, Willis GB. Research Synthesis: the practice of cognitive interviewing. Pub Opin Q. 2007;71(2):287–311.
Nikiphorou E, Lempp H, Kohrt BA. Treatment failure in inflammatory arthritis: time to think about syndemics? Rheumatology (Oxford. England). 2019;58(9):1526–33.
Sell L, Bültmann U, Rugulies R, Villadsen E, Faber A, Søgaard K. Predicting long-term sickness absence and early retirement pension from self-reported work ability. Int Arch Occupa Environ Health. 2009;82(9):1139.
Jensen NH, Aaby A, Ryom K, Maindal HT. A CHAT about health literacy – a qualitative feasibility study of the Conversational Health Literacy Assessment Tool (CHAT) in a Danish municipal healthcare centre. Scand J Caring Sci. 2021;35(4):1250–8.
Beaton DE, Dyer S, Boonen A, Verstappen SM, Escorpizo R, Lacaille DV, et al. OMERACT filter evidence supporting the measurement of at-work productivity loss as an outcome measure in rheumatology research. J Rheumatol. 2016;43(1):214–22.
Boekel I, Dutmer AL, Schiphorst Preuper HR, Reneman MF. Validation of the work ability index-single item and the pain disability index-work item in patients with chronic low back pain. Eur Spine J. 2022;31(4):943–52.
Ebener M, Hasselhorn HM. Validation of short measures of work ability for research and employee surveys. Int J Environ Res Public Health. 2019;16(18):3386.
Braakman-Jansen LMA, Kuper IH, van de Laar MAFJ, Taal E. Productivity loss due t o absenteeism and presenteeism by different instruments in patients with RA and subjects without RA. Rheumatology (Oxford). 2012;51(2):354–61.
Zhang W, Bansback N, Boonen A, Young A, Singh A, Anis AH. Validity of the work productivity and activity impairment questionnaire - general health version in patients with rheumatoid arthritis. Arthrit Res Ther. 2010;12(5):R177–R.
Pilgaard T, Esbensen BA, Stallknecht SE, PARE0006 work, productivity loss in patients with inflammatory arthritis. Annal Rheum Dis. 2020;79(Suppl 1):1289.
Denmark’s statistics. Sick leave in Denmark 2021 [ www.dst.dk/nyt/42792
Jørgensen MD, Christensen M, Buhelt AI, Tolstrup LP, Leddegigt i Danmark JS. Nøgletal. 2018. (Rheumatoid Arthritis in Denmark. Key numbers 2018). Statens Institut for Folkesundhed, SDU (National Institute for Public Health, University of Southern Denmark); 2018.
Mairey IP, Bihrmann K, Holmberg T, Davidsen M, Lassen TH. Muskel- Og Skeletlidelser i Danmark. Syddansk Universitet; 2022.
Hammond A, O’Brien R, Woodbridge S, Bradshaw L, Prior Y, Radford K, et al. Job retention vocational rehabilitation for employed people with inflammatory arthritis (WORK-IA): a feasibility randomized controlled trial. BMC Musculoskelet Disord. 2017;18(1):315.
Helsinki Declaration World Medical Association. [ https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/
Acknowledgements
We would like to thank all participants and RCs involved in WORK-ON.
Funding
Open access funding provided by University of Southern Denmark. WORK-ON is supported by the Region of Southern Denmark, Knud and Edith Eriksen’s Memorial Fund, the Danish Rheumatism Association, the Danish Association of Occupational Therapists, and the DHRD.
Author information
Authors and Affiliations
Contributions
All authors have read and corrected draft versions of the manuscript and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This study complied with the ethical principles recommended by the Danish Ministry of Higher Education and Science and the Declaration of Helsinki [58]. In accordance with Danish national legislation, register research projects, interview surveys, and questionnaire surveys need only be approved if human biological material is included in the project (National Committee for Health Research Ethics: https://en.nvk.dk/rules-and-guidelines/act-on-researchethics-review-of-health-research-projects). As this study does not include human biological material, ethical approval is unnecessary. This has been confirmed by The Regional Committee on Health Ethics for Southern Denmark (20192000-105). All participants in the interviews [16] and workshops received written information about the study and informed written consent was obtained before participation. The participants were informed participation was voluntary and they could withdraw at any time until the results were analyzed and WORK-ON was ready for feasibility testing. Clinical trial number: not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Madsen, C.M.T., Christensen, J.R., Bremander, A. et al. Feasibility test of WORK-ON: a vocational rehabilitation intervention for people with chronic inflammatory arthritis. BMC Musculoskelet Disord 25, 755 (2024). https://doi.org/10.1186/s12891-024-07862-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12891-024-07862-8